LYON, France, Feb. 24, 2012 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced today that Ablatherm® High Intensity Focused Ultrasound (HIFU) will be featured in seven poster presentations supporting the technology’s efficacy for the treatment of localized prostate cancer, and two of these presentations have been awarded “Best Posters” highlighting HIFU clinical data relevance. Ablatherm-HIFU and the Company’s renewed lithotripsy Sonolith product range will be showcased at the 27th Annual European Association of Urology (EAU) Congress, which will be held on February 24 – 28 in Paris, France.
